American Academy of Neurology: New Drug to Prevent Migraine May Start Working Right Away
December 24, 2024
December 24, 2024
MINNEAPOLIS, Minnesota, Dec. 24 (TNSres) -- The American Academy of Neurology issued the following news release:
A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, 2024, online issue of Neurology(R), the medical journal of the American Academy of Neurology. The study looked at the drug atogepant, which is a calcitonin gene-related peptide (CGRP) receptor antagonist taken by mouth.
"With many . . .
A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, 2024, online issue of Neurology(R), the medical journal of the American Academy of Neurology. The study looked at the drug atogepant, which is a calcitonin gene-related peptide (CGRP) receptor antagonist taken by mouth.
"With many . . .